Year: 2025

WATERTOWN, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the pricing of the upsized underwritten offering of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. Disc is selling 2,619,049 shares of common stock and pre-funded warrants to purchase 59,523 shares of common stock and AI DMI LLC (the Selling Stockholder) is selling 297,619 shares of common stock in the offering. The shares of common stock are being sold at an offering price of $84.00 per share, and the pre-funded warrants are being sold...

TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (the “Company”), reports that Mr. Marin Katusa (the “Acquiror”), the Chief Executive Officer of the Company, has purchased 74,500 common shares of the Company (the “Acquired Shares”) on the open market through the facilities of the Cboe Canada Exchange at the market price of $0.67 per Acquired Share for an aggregate purchase price of $49,915 (the “Acquisition”). Prior to the Acquisition, the Acquiror owned or controlled an aggregate of 4,101,000 common shares of the Company (“Common Shares”) and 1,170,000 Common Share purchase warrants (“Warrants”). The 4,101,000 Common Shares owned or controlled by the Acquiror prior to the Acquisition represented approximately 8.5% of the total number of issued and outstanding Common...

SINGAPORE, Oct. 20, 2025 (GLOBE NEWSWIRE) — BGIN BLOCKCHAIN LIMITED (“BGIN” or “the Company”) (Nasdaq: BGIN), a digital asset technology company with proprietary cryptocurrency-mining technologies, today announced the pricing of its initial public offering (the “Offering”) of 5,000,000 Class A ordinary shares, at an initial public offering price of US$6.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq Global Market and are expected to begin trading on October 21, 2025, under the symbol “BGIN.” The total gross proceeds to the Company from the Offering are expected to be approximately US$30 million, before deducting underwriting discounts and other related expenses. The Company has granted the underwriters an over-allotment option, exercisable within 45 days after the closing of this Offering,...

MoneyHero strengthens brand leadership and monetisation with 3,800-attendee Seedly Personal Finance Festival in Singapore Strong attendance signals strong demand for financial guidance amid economic uncertainty The Seedly x SingSaver Personal Finance Festival featured over 65 speakers, including Acting Minister for Transport and Senior Minister of State for Finance Jeffrey SiowSINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today announced the successful conclusion of the Seedly x SingSaver Personal Finance Festival (PFF), which attracted more than 3,800 attendees at the Marina Bay Sands Expo & Convention Centre. Now in its sixth...

LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) — BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate 15,000,000 shares of common stock of BrightSpring. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering. The offering is expected to close on October 22, 2025, subject to customary closing conditions. In addition, the Company has authorized, subject to the completion...

CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that a press release that had previously been issued on April 17, 2025 was re-issued in error today. Please disregard this prior press release.   XORTX announces that it received today a notice (the “Extension Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180-day extension to regain compliance with the minimum bid price requirement (“Minimum Bid Requirement”) of US$1.00 per share under the Nasdaq Rule 5550(a)(2). The Company was first notified by Nasdaq that is was non-compliant with the...

VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company”, TSXV: VRR) is pleased to announce that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent”) as lead agent and sole bookrunner in connection with a brokered private placement. The Company initially plans to raise up to $1.5M (the “Offering“) through the sale of up to 15M units (“Units“) at a post-Consolidation issue price of $0.10 per Unit (the “Issue Price”), on a commercially reasonable efforts basis. Each Unit shall consist of one common share in the capital of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”). Each full Warrant shall entitle the holder thereof to purchase one Share (a “Warrant Share”) at a post-Consolidation price of $0.16 (the “Exercise Price”)...